Størmer F C, Kolsaker P, Holm H, Rogstad S, Elling F
Appl Environ Microbiol. 1985 May;49(5):1108-12. doi: 10.1128/aem.49.5.1108-1112.1985.
A metabolic product was formed from ochratoxin B by rat liver microsomal fractions in the presence of NADPH. It was isolated from the incubation mixture by extraction, thin-layer chromatography, high-pressure liquid chromatography, and crystallization. On the basis of mass and nuclear magnetic resonance spectroscopy, the structure is suggested to be 4-hydroxyochratoxin B. The Km for the formation of 4-hydroxyochratoxin B was determined, and the hydroxylation of ochratoxin A was not altered by the presence of ochratoxin B. Rats were given ochratoxin A or B, or a mixture of both intraperitoneally. The ratios of the three metabolites, ochratoxin A, (4R)-4-hydroxyochratoxin A, and ochratoxin alpha, excreted in the urine did not change in the presence of ochratoxin B. Ochratoxin B was metabolized to 4-hydroxyochratoxin B and ochratoxin beta, but in a different ratio than for the ochratoxin A metabolites. When given intraperitoneally, ochratoxin beta was excreted within 24 h. In rats treated with ochratoxin A alone, the food intake was reduced by 50%, and histologically severe lesions, degeneration, and necrosis were observed in the proximal tubules. When ochratoxin A and B given in combination, the animals were clinically unaffected and histologically there was only slight damage of proximal tubules. These observations indicate that ochratoxin B considerably reduces the toxic effects of ochratoxin A.
在NADPH存在的情况下,大鼠肝脏微粒体组分可将赭曲霉毒素B转化为一种代谢产物。通过萃取、薄层色谱法、高压液相色谱法和结晶法从孵育混合物中分离出该产物。基于质谱和核磁共振光谱分析,推测其结构为4-羟基赭曲霉毒素B。测定了4-羟基赭曲霉毒素B形成的米氏常数,且赭曲霉毒素B的存在并未改变赭曲霉毒素A的羟基化作用。给大鼠腹腔注射赭曲霉毒素A或B,或两者的混合物。在存在赭曲霉毒素B的情况下,尿液中排泄的三种代谢产物——赭曲霉毒素A、(4R)-4-羟基赭曲霉毒素A和赭曲霉毒素α的比例并未发生变化。赭曲霉毒素B被代谢为4-羟基赭曲霉毒素B和赭曲霉毒素β,但其比例与赭曲霉毒素A的代谢产物不同。腹腔注射后,赭曲霉毒素β在24小时内排出。单独用赭曲霉毒素A处理的大鼠,食物摄入量减少了50%,组织学检查发现近端小管出现严重病变、变性和坏死。当联合给予赭曲霉毒素A和B时,动物在临床上未受影响,组织学检查仅发现近端小管有轻微损伤。这些观察结果表明,赭曲霉毒素B可显著降低赭曲霉毒素A的毒性作用。